Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07641387Recruiting
Single-arm trial, sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: Number of Participants with Live Birth Following Assisted Reproductive Technology (ART) Treatment at 42 weeks and Number of Participants with ART Treatment Failure (Composite Outcome) at 42 weeks. Started Apr 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07641387.